The chemical class of VR1 activators encompasses a diverse group of compounds that can either directly or indirectly modulate the activity of the vanilloid receptor 1 (VR1), also known as the transient receptor potential vanilloid 1 (TRPV1). VR1 is a non-selective cation channel predominantly expressed in sensory neurons, where it plays a crucial role in the detection of noxious stimuli, including heat and certain chemical irritants. The identified VR1 activators exhibit a range of mechanisms to influence the activation of this ion channel. Direct activators of VR1 include capsaicin, resiniferatoxin, and olvanil. Capsaicin, found in chili peppers, directly binds to VR1, leading to channel opening and the sensation of heat or pain. Resiniferatoxin, a potent analog of capsaicin, similarly activates VR1 by binding to its ligand-binding pocket. Olvanil, a synthetic vanilloid compound, mimics capsaicin's structure and directly activates VR1, inducing neuronal excitation through cation influx, particularly calcium ions.
Indirect activators of VR1 involve compounds such as 2-APB, anandamide, and probenecid. 2-APB indirectly activates VR1 by modulating intracellular calcium levels. It inhibits inositol trisphosphate receptors (IP3Rs), leading to increased cytoplasmic calcium concentrations, which sensitize VR1 channels. Anandamide, an endogenous cannabinoid, indirectly activates VR1 by interacting with cannabinoid receptors, resulting in decreased cyclic AMP levels and enhanced VR1 response. Probenecid indirectly activates VR1 by inhibiting anion channels, causing membrane depolarization and subsequent VR1 activation. Further indirect activators include arachidonic acid, bradykinin, lysophosphatidic acid (LPA), and GSK1016790A. Arachidonic acid indirectly activates VR1 by acting as a substrate for lipoxygenases, producing leukotrienes that sensitize VR1 channels. Bradykinin activates VR1 indirectly through B2 receptor (B2R) signaling, involving phospholipase C (PLC) activation and intracellular calcium release. LPA activates VR1 indirectly via LPA receptor signaling, leading to increased intracellular calcium and sensitization of VR1. GSK1016790A indirectly influences VR1 activation by activating TRPV4 channels, modulating intracellular calcium levels and affecting VR1-regulated pathways.